Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial

Completed · Phase 3 · Has a placebo group

Conditions studied: Cerebrovascular Accident

In brief

The goal of this study is to evaluate the effectiveness and safety of field-initiated magnesium sulfate in improving the long-term functional outcome of patients with acute stroke.

Key facts

Study ID

NCT00059332

Run by

Jeffrey L. Saver

People needed

1700

Starts

2005-01-01

Expected to finish

2013-03-01

Last updated by the study team

2015-08-21

Who can join

Age: 40 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Suspected stroke identified by the Los Angeles Prehospital Stroke Screen
• Age 40-95, inclusive
• Last known well time within 2 hours of treatment initiation
• Deficit present for >/= 15 minutes

You may not qualify if…

• Coma
• Rapidly improving neurologic deficit
• Pre-existing neurologic, psychiatric, or advanced systemic disease that would confound the neurological or functional outcome evaluations
• Systolic Blood Pressure (SBP) < 90 or > 220
• Known severe renal dysfunction (on dialysis or known chronic creatinine > 3.0)
• Severe respiratory distress (O2 sat < 90% or respiratory rate < 12 or >/= 24)
• Known second or third degree heart block with no pacemaker in place
• Major head trauma in the last 24 hours
• Recent stroke within prior 30 days
• Patient unable to give informed consent and no available on scene consent or assent provider

Where it is running

• The Clinical Coordinating Center is: UCLA School of Medicine, 710 Westwood Plaza — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.